EN PL
OPIS PRZYPADKU
When nuisance is nice: ignored erythema nodosa heralding the Löfgren’s syndrome in a Nigerian woman
 
Więcej
Ukryj
 
Data nadesłania: 12-08-2017
 
 
Data ostatniej rewizji: 05-10-2017
 
 
Data akceptacji: 23-10-2017
 
 
Data publikacji online: 28-10-2017
 
 
Data publikacji: 31-10-2017
 
 
Reumatologia 2017;55(5):261-264
 
SŁOWA KLUCZOWE
DZIEDZINY
STRESZCZENIE
Löfgren’s syndrome (LS) is a variant of sarcoidosis characterised by the triad of erythema nodosum (EN), radiographic bilateral hilar adenopathy, and arthralgia/arthritis. Like all cases of sarcoidosis, it is of unknown aetiology and may constitute a diagnostic difficulty in the ambiguous phenotype. Löfgren’s syndrome is associated with a good prognosis and commonly undergoes spontaneous remission within four months. However, the co-existence of multiple good and adverse prognostic factors in a patient may call for guarded expectation. Sarcoidosis is generally more prevalent among people of African descent, but the vast majority of the literature on sarcoidosis are from the western hemisphere. Löfgren’s syndrome has been rarely documented in West Africans despite the availability of some reports of sarcoidosis in the region. We present a case of a Nigerian woman with LS that started out as isolated EN, which was ignored for months until the onset of florid pulmonary and systemic symptoms.
 
REFERENCJE (19)
1.
Kobak S. Sarcoidosis: a rheumatologist’s perspective. Ther Adv Musculoskelet Dis 2015; 7: 196-205.
 
2.
Hosoda Y, Sasagawa S, Yasuda N. Epidemiology of sarcoidosis: new frontiers to explore. Curr Opin Pulm Med 2002; 8: 424-428.
 
3.
Rybicki BA, Major M, Popovich J Jr, et al. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol 1997; 145: 234-241.
 
4.
Grunewald J, Eklund A. Human leukocyte antigen genes may outweigh racial background whengenerating a specific immune response in sarcoidosis. Eur Respir J 2001; 17: 1046-1048.
 
5.
Higashimoto I, Arata SI, Niena K. A case of acute sarcoidosis with polyarthralgia and erythemanodosum: Lofgren’s syndrome. Nihon Kokyuki Gakkai Zasshi 2002; 40: 679-682.
 
6.
Visser H, Vos K, Zanelli E, et al. Sarcoid arthritis: clinical characteristics, diagnostic aspects, and risk factors. Ann Rheum Dis 2002; 61: 499-504.
 
7.
Martinetti M, Tinelli C, Kolek V, et al. “The sarcoidosis map”: a joint survey of clinical and immunogenetic findings in two European countries. Am J Respir Crit Care Med 1995; 152: 557-564.
 
8.
Jacyk WK. Sarcoidosis in the West African. A report of eight Nigerian patients with cutaneous lesions. Trop Geogr Med 1984; 36: 231-236.
 
9.
Olumide YM, Bandele EO, Elesha SO. Cutaneous sarcoidosis in Nigeria. J Am Acad Dermatol 1989; 21: 1222-1224.
 
10.
Baughman RP, Lower EE. Features of sarcoidosis associated with chronic disease. Sarcoidosis Vasc Diffuse Lung Dis 2015; 31: 275-281.
 
11.
Rao DA, Dellaripa PF. Extrapulmonary manifestations of sarcoidosis. Rheum Dis Clin North Am 2013; 39: 277-297.
 
12.
Spagnolo P, Renzoni EA, Wells AU, et al. Chemokine receptor 2 and sarcoidosis: association with Lofgren’s syndrome. Am J Respir Crit Care Med 2003; 168: 1162-1166.
 
13.
Valentonyte R, Hampe J, Croucher PJ, et al. Study of C-C chemokine receptor 2 alleles in sarcoidosis, with emphasis on family-based analysis. Am J Respir Crit Care Med 2005; 171:m1136-1141.
 
14.
Grunewald J. HLA associations and Lofgren’s syndrome. Expert Rev Clin Immunol 2012; 8: 55-62.
 
15.
Kobak S, Sever F, Sivrikoz ON, et al. Sarcoidois: is it only a mimicker of primary rheumatic disease? A single center experience. Ther Adv Musculoskelet Dis 2014; 6: 3-7.
 
16.
Ungprasert P, Carmona EM, Crowson CS, et al. Diagnostic Utility of Angiotensin-Converting Enzyme in Sarcoidosis: A Population-Based Study. Lung 2016; 194: 91-95.
 
17.
Alabi GO, George AO. Cutaneous sarcoidosis and tribal scarifications in West Africa. Int J Dermatol 1989; 28: 29-31.
 
18.
Antonovich DD, Callen JP. Development of sarcoidosis in cosmetic tattoos. Arch Dermatol 2005; 141: 869-872.
 
19.
Fleischer M, Hinz A, Brähler E, et al. Factors associated with fatigue in sarcoidosis. Respir Care 2014; 59: 1086-1094.
 
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
eISSN:2084-9834
ISSN:0034-6233
Journals System - logo
Scroll to top